[Federal Register Volume 83, Number 238 (Wednesday, December 12, 2018)]
[Notices]
[Page 63905]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-26861]


-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation No. 731-TA-1110 (Second Review)]


Sodium Hexametaphosphate From China

Determination

    On the basis of the record \1\ developed in the subject five-year 
review, the United States International Trade Commission 
(``Commission'') determines, pursuant to the Tariff Act of 1930 (``the 
Act''), that revocation of the antidumping duty order on sodium 
hexametaphosphate from China would be likely to lead to continuation or 
recurrence of material injury to an industry in the United States 
within a reasonably foreseeable time.\2\
---------------------------------------------------------------------------

    \1\ The record is defined in sec. 207.2(f) of the Commission's 
Rules of Practice and Procedure (19 CFR 207.2(f)).
    \2\ Commissioner Meredith M. Broadbent did not participate in 
the vote.
---------------------------------------------------------------------------

Background

    The Commission, pursuant to section 751(c) of the Act (19 U.S.C. 
1675(c)), instituted this review on June 1, 2018 (83 FR 25488) and 
determined on September 4, 2018 that it would conduct an expedited 
review (83 FR 50958, October 10, 2018).
    The Commission made this determination pursuant to section 751(c) 
of the Act (19 U.S.C. 1675(c)). It completed and filed its 
determination in this review on December 7, 2018. The views of the 
Commission are contained in USITC Publication 4840 (December 2018), 
entitled Sodium Hexametaphosphate from China: Investigation No. 731-TA-
1110 (Second Review).

    By order of the Commission.

    Issued: December 7, 2018.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2018-26861 Filed 12-11-18; 8:45 am]
 BILLING CODE 7020-02-P